Skip to main content

Eton Pharmaceuticals, Inc.

For the period ended Mar 31, 2026. Filed May 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

ETON$56.46+19.7%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Part NoItem NoDescriptionPage No.
IFINANCIAL INFORMATION1
1Financial Statements1
Condensed Balance Sheets as of March 31, 2026 (unaudited) and December 31, 20251
Unaudited Condensed Statements of Operations for the three months ended March 31, 2026 and 20252
Unaudited Condensed Statements of Stockholders’ Equity for the three months ended March 31, 2026 and 20253
Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2026 and 20254
Notes to Condensed Financial Statements5
2Management’s Discussion and Analysis of Financial Condition and Results of Operations18
3Quantitative and Qualitative Disclosures About Market Risk22
4Controls and Procedures23
IIOTHER INFORMATION24
1Legal Proceedings24
1ARisk Factors24
2Unregistered Sales of Equity Securities and Use of Proceeds24
3Defaults Upon Senior Securities24
4Mine Safety Disclosures24
5Other Information24
6Exhibits24
Exhibit Index25
Signatures26

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.